Achmea IM to vote against pharma pay unless tied to access to medicine

Dutch manager to target pharma pay as it sends follow-up letter to key players as head of $1.8trn investor group pushing for fairer access to medicines.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.